US · Healthcare · Medical Care Facilities
EPS came in at 0.41 against a street estimate of 0.37 — a beat of 10.8%.
Analysts rate Option Care Health Inc a hold (0 buy, 11 hold, 0 sell out of 11) with an average price target of $30.03.
MIXED Option Care beat Q2 expectations on revenue, EBITDA, and EPS; CID portfolio stabilizing; commercial reset gaining traction. Guidance unchanged but ranges narrowed. Sequential growth expected to accelerate into Q4. Q2 2026 No geographic segment breakdown provided. Analysts pressed on Q3–Q4 ramp drivers, cost-cut assumptions vs. revenue leverage, and white-bagging risk. Management emphasized revenue and commercial productivity as primary guidance engines, with cost initiatives supporting but not leading growth. 2026-07-29…
Full summary in the app.
| Fund | Stake |
|---|---|
| BlackRock Inc | 14.09% |
| Wellington Management Company LLP | 7.51% |
| Vanguard Portfolio Management, LLC | 5.28% |
| Fuller & Thaler Asset Management Inc | 4.75% |
| Vanguard Capital Management, LLC | 4.50% |
| Durable Capital Partners LP | 3.93% |
| State Street Corp | 3.91% |
| Arrowstreet Capital Limited Partnership | 3.81% |
| Document | Date |
|---|---|
| Material agreement · Q4 2026 HEADLINE NUMBERS • Option Care Health entered into an agreement on October 5, 2026, to be acquired by an investor group consisting of affiliates of C | 2026-10-06 |
| Quarterly report · Q2 2026 OPTION CARE HEALTH, INC. - Q2 2026 10-Q SUMMARY HEADLINE NUMBERS • Net Revenue (Q2 2026): $1,442.4 million, up 1.9% vs Q2 2025 ($1,416.1 million) • | 2026-07-29 |
| Results announced · Q3 2026 OPTION CARE HEALTH Q2 2026 FINANCIAL RESULTS SUMMARY HEADLINE NUMBERS • Net Revenue: $1,442 million in Q2 2026, up 1.9% year-over-year • GAAP Net In | 2026-07-29 |
| Shareholder vote results · Q2 2026 OPTION CARE HEALTH, INC. – FORM 8-K SUMMARY HEADLINE NUMBERS • Annual Meeting held May 20, 2026 • All nine director nominees elected with strong sha | 2026-05-22 |
| Reg FD disclosure · Q2 2026 OPTION CARE HEALTH, INC. – FORM 8-K SUMMARY HEADLINE NUMBERS • No specific financial results disclosed in this filing • Document is a current report | 2026-05-12 |
| Board / officer change · Q2 2026 OPTION CARE HEALTH, INC. – FORM 8-K SUMMARY BUSINESS & SEGMENT HIGHLIGHTS • Company: Option Care Health, Inc. (NASDAQ: OPCH), a Delaware-incorporate | 2026-05-05 |
| Quarterly report · Q1 2026 OPTION CARE HEALTH, INC. – Q1 2026 10-Q SUMMARY HEADLINE NUMBERS • Net Revenue Q1 2026: $1,350.7 million (up $17.7 million or 1.3% vs. Q1 2025's $1, | 2026-04-30 |
| Proxy statement · Q2 2026 OPTION CARE HEALTH, INC. — PROXY SUMMARY FOR RETAIL INVESTORS --- CEO TOTAL COMPENSATION This proxy statement does not contain complete 2025 compen | 2026-04-08 |
Readable in the app.
| Announcement | Date |
|---|---|
| Company to be acquired by affiliates of Clayton Dubilier Rice and McKesson Option Care Health agreed to be acquired by an investor group led by Clayton, Dubilier & Rice and McKesson. The transaction will make Option Care a privately held, wholly owned subsidiary of | 2026-10-06 |
| Board approves increase to share repurchase program authorization to $1 billion Option Care Health announced preliminary 2025 financial results and 2026 guidance on January 12, 2026. While specific financial figures aren't detailed in this 8-K filing itself, the company | 2026-01-12 |
Technicals, trade setups with a published hit rate, AI analysis and earnings-call summaries for Option Care Health Inc — free to start.
Open in the appGoogle PlayApp StoreData updated 2026-10-19.